iCad Inc. (NSDQ:ICAD) won a patent from the U.S. Patent and Trademark Office for its SecondLook Digital Computer-Aided Detection system, covering "lesion metrics" used to provide radiologists with enhanced clinical information.
The Nashua, N.H.-based company, which makes CAD systems for detecting cancer, also won a patent for computed tomography image analysis software designed to improve three-dimensional assessment of imaging data, according to a press release.
Last year iCad got a nod from another federal agency when the Food & Drug Administration granted 510(k) approval for its PrecisionPoint software designed to locate the best point to perform a needle biopsy of the breast.
iCad posted a $317,000 profit, or 1 cent per share, on $8.1 million in revenues during the three months ended Dec. 31, 2009. That compares with net income of $321,000 on $9.3 million in revenues during the fourth quarter of 2008.